(Reuters) - The ads, which appeared in newspapers such as The New York Times, The Washington Post, USA Today and The Wall Street Journal, take the form of a letter to Avandia patients signed by Ronald Krall, chief medical officer of the world's second-largest drugmaker.
The unusual step comes a day before a scheduled U.S. congressional hearing on the Food and Drug Administrations role in evaluating the safety of Avandia, and a day after the first solid data became available on the medicine's eroding prescription numbers.
Read more at Reuters.com Government Filings News
The unusual step comes a day before a scheduled U.S. congressional hearing on the Food and Drug Administrations role in evaluating the safety of Avandia, and a day after the first solid data became available on the medicine's eroding prescription numbers.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment